ESR1 and breast cancer: In a recent study using RNA expression data from clinically matched estrogen receptor positive (ER+) cases (n = 16), postpartum breast cancer had pronounced T-cell presence and T-cell activation/exhaustion signatures, reduced TP53 activity, reduced ER signaling, and increased cell cycle gene signatures compared with breast cancer in nulliparous women (53).